| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.19 | 6e-06 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.29 | 9e-06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-06 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |